[Bullous amyloïdis revealing a light chains lambda myeloma]
Z Reguiaï1, K Aïnine, V Rémy-Leroux
1Service de Dermatologie, Hôpital Robert-Debré, CHU de Reims, 51092 Reims, France. ziad.reguiai@club-internet.fr
La Revue De Medecine Interne
|August 26, 2006
Summary
Bullous amyloidosis, a rare skin condition, can signal underlying light chain lambda myeloma. Early detection of these skin lesions is crucial for timely treatment and preventing lethal systemic amyloidosis.
Area of Science:
- Dermatology
- Hematology
- Pathology
Background:
- Systemic amyloidosis can manifest with skin lesions, though bullous presentations are exceptionally rare.
- Only thirty cases of bullous amyloidosis have been previously documented in medical literature.
Observation:
- An 85-year-old male presented with a bullous eruption and general asthenia.
- Diagnosis of bullous amyloidosis linked to light chain lambda myeloma was confirmed via skin biopsy.
- The patient experienced rapid deterioration due to cardiac amyloidosis, leading to death within 15 days.
Findings:
- Bullous amyloidosis can serve as an early indicator of occult dysglobulinemia.
- The case highlights the diagnostic significance of skin biopsy in identifying underlying plasma cell disorders.
Implications:
- Prompt diagnosis of bullous amyloidosis allows for early intervention before systemic disease progression.
- Timely treatment may prevent the development of severe, potentially fatal, systemic amyloidosis and its complications.
